HAMP and cancer: In addition, CEACAM4 was enriched in VEGF signaling pathway (p‐value: 0.027) and MAPK signaling pathway (p‐value: 0.040) and HAMP was significantly associated with pathways in cancer (p‐value: 3.24e−04) and MAPK signaling pathway (p‐value: 6.98e−03) (Figure 9).